Zobrazeno 1 - 4
of 4
pro vyhledávání: '"Outi Ahdesmäki"'
Autor:
James Brockbank, Taryn Krause, Emily Moss, Anne Milthers Pedersen, Michael Frank Mørup, Outi Ahdesmäki, Jake Vaughan, Thor-Henrik Brodtkorb
Publikováno v:
Health and Quality of Life Outcomes, Vol 19, Iss 1, Pp 1-17 (2021)
Abstract Background Major depressive disorder (MDD) is associated with decreased patient well-being and symptoms that can cause substantial impairments in patient functioning and even lead to suicide. Worldwide, MDD currently causes the second-most y
Externí odkaz:
https://doaj.org/article/940d011163b844269fe36ebe80b4d2f3
Autor:
Matthew Lyall, Christopher Knight, Douglas Veale, Ana Marín-Sánchez, Louise Hartley, Judith Bell, Clive McKimmie, David Gálvez Ruiz, Annete Njue, Josephine Mauskopf, Sinisa Savic, Takafumi Tomizuka, Stacey Chang-Douglass, Piotr Wiland, Outi Ahdesmäki, FAHD ADEEB
Publikováno v:
Arthritis & Rheumatology. 70:1-3584
Autor:
Emma Hawe, Jean-Gabriel Le Moine, Claire Ainsworth, Judith Bell, Eric M Maiese, Outi Ahdesmäki
Publikováno v:
Clinical Therapeutics. 40:480-494.e23
Purpose New therapies, including daratumumab plus lenalidomide plus dexamethasone (DRd) and daratumumab plus bortezomib plus dexamethasone (DVd), have recently been approved in the United States for patients with multiple myeloma (MM) who have receiv
Publikováno v:
Journal of Clinical Oncology. 35:8042-8042
8042 Background: Treatment for multiple myeloma (MM) in the US has undergone significant advances, with several new therapies recently FDA approved for relapse/refractory MM (RRMM), including carfilzomib+lenalidomide+dex (KRd), carfilzomib+dex (Kd),